New pharmacological agents for arrhythmias.
Division of Cardiovascular Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA.
Pamela K
PK
Mason
John P
JP
DiMarco
D000083:Acetanilides / Q000494:pharmacology; D058907:Adenosine A1 Receptor Agonists; D000638:Amiodarone / Q000031:analogs & derivatives* / Q000494:pharmacology; D000840:Anisoles / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001552:Benzazepines / Q000494:pharmacology; D001572:Benzofurans / Q000494:pharmacology; D002986:Clinical Trials as Topic; D000077764:Dronedarone; D006801:Humans; D000077550:Ivabradine; D010879:Piperazines / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D000069458:Ranolazine
D000083:Acetanilides; D058907:Adenosine A1 Receptor Agonists; D000840:Anisoles; D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D001572:Benzofurans; D010879:Piperazines; D011759:Pyrrolidines; D000077550:Ivabradine; C524581:vernakalant; D000069458:Ranolazine; C545283:budiodarone; D000077764:Dronedarone; C499879:celivarone; D000638:Amiodarone